Commercialization Center for Innovative Technologies, Suite B203 — North Brunswick, New Jersey

Commercialization Center for Innovative Technologies, Suite B203 is a clinical research site located in North Brunswick, New Jersey, United States 08902.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Commercialization Center for Innovative Technologies, Suite B203 has participated in 1 clinical trials.

Therapeutic areas: Healthy.

Sponsors: Bright Cloud International Corp.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Commercialization Center for Innovative Technologies, Suite B203?

Commercialization Center for Innovative Technologies, Suite B203 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Commercialization Center for Innovative Technologies, Suite B203 conducted?

Commercialization Center for Innovative Technologies, Suite B203 has 1 clinical trials on record. Their work covers Healthy.

Is Commercialization Center for Innovative Technologies, Suite B203 accredited by Crixeo Health?

Commercialization Center for Innovative Technologies, Suite B203 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Commercialization Center for Innovative Technologies, Suite B203?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.